Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,824.66
(
0.62%
)
US TECH 100
24,372.00
(
0.53%
)
Dow Jones
48,185.80
(
0.58%
)
Brent Oil
94.24
(
-0.63%
)
Bitcoin
72,376.10
(
1.75%
)
News Focus
News Focus
Post# of 257375
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 71
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: bladerunner1717 post# 135105

Monday, 01/16/2012 10:37:26 AM

Monday, January 16, 2012 10:37:26 AM

Post# of 257375
Cldx:

As per usual, I do not believe that such peptide immunotherapeutics elicit a sufficient immune response. I would personally stay away from cldx even if that means I miss out on a phase iii success.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now